[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@OncoThor Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::814218641579376641.png) @OncoThor Thor Halfdanarson

Thor Halfdanarson posts on X about g3, radar, threshold the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::814218641579376641/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::814218641579376641/c:line/m:interactions.svg)

- X Week XXXXX +97%
- X Month XXXXX +6,250%
- X Months XXXXXX +4.90%
- X Year XXXXXXX +123%

### Mentions: X [#](/creator/twitter::814218641579376641/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::814218641579376641/c:line/m:posts_active.svg)


### Followers: XXXXX [#](/creator/twitter::814218641579376641/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::814218641579376641/c:line/m:followers.svg)

- X Week XXXXX +0.36%
- X Month XXXXX +2.50%
- X Months XXXXX +9.30%
- X Year XXXXX +17%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::814218641579376641/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::814218641579376641/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::814218641579376641/influence)
---

**Social category influence**
[stocks](/list/stocks) 

**Social topic influence**
[g3](/topic/g3), [radar](/topic/radar), [threshold](/topic/threshold)
### Top Social Posts [#](/creator/twitter::814218641579376641/posts)
---
Top posts by engagements in the last XX hours

"On my NET PubMed radar this morning from @rohit_thum et al. at MSKCC. DLL3 positive in XX% of GEPNECs and XX% of well diff G3 panc NETs and DLL3+ was associated with worse outcomes in that group. Check it out @lisabodei @DianeReidyLagun @natasharekhtman"  
![@OncoThor Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::814218641579376641.png) [@OncoThor](/creator/x/OncoThor) on [X](/post/tweet/1946188479005589987) 2025-07-18 12:41:06 UTC 5028 followers, 2664 engagements


"@rohit_thum @AnisToumeh @lisabodei @DianeReidyLagun @natasharekhtman I agree and second the comment on Amgen. We have treated a few pts with NECs but not yet a G3 NET patient but we are routinely staining for DLL3 now. Also agree with the comment on the DLL3 threshold. With obrixtamig XX% threshold may be reasonable right @Ja_Capdevila"  
![@OncoThor Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::814218641579376641.png) [@OncoThor](/creator/x/OncoThor) on [X](/post/tweet/1946214136783794270) 2025-07-18 14:23:03 UTC 5029 followers, XXX engagements


"@DianeReidyLagun @rohit_thum Agree there is a large unmet need for later lines of G3 pNETs and for refractory lung NETs. Trials needed for DLL3-targeting agents in these cohorts are definitely needed. Strong work Lots of goodies in the manuscript so NET folks check it out"  
![@OncoThor Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::814218641579376641.png) [@OncoThor](/creator/x/OncoThor) on [X](/post/tweet/1946190428006400117) 2025-07-18 12:48:51 UTC 5025 followers, XXX engagements